Impact of the viability assessment of lateral lymph node metastasis in rectal cancer after neoadjuvant chemoradiotherapy
Impact of the viability assessment of lateral lymph node metastasis in rectal cancer after neoadjuvant chemoradiotherapy
复制标题
直肠癌新辅助放化疗后侧方淋巴结转移活力评估的影响
DOI:
10.1007/s00384-021-04085-4
复制
发表时间:
2022
影响因子:
2.8
通讯作者:
Ishihara Soichiro
中科院分区:
文献类型:
--
作者:
Ozaki Kosuke;Kawai Kazushige;Nozawa Hiroaki;Sasaki Kazuhito;Murono Koji;Emoto Shigenobu;Abe Hiroyuki;Ushiku Tetsuo;Ishihara Soichiro
PurposePreoperative chemoradiotherapy (CRT) followed by total mesorectal excision (TME) without lateral lymph node (LLN) dissection is widely performed for lower advanced rectal cancer. However, it is unclear whether residual cancer cells in the LLNs undergo apoptosis, disappear, or regrow if unresected.MethodsOverall, 293 consecutive patients with T3/4 rectal cancer who underwent CRT followed by radical surgery between September 2003 and December 2018 were retrospectively reviewed. We assessed apoptosis of the residual primary tumor, mesorectum lymph nodes (MLN), and LLN using M30 cytoDEATH immunostaining and evaluated the degree of apoptosis. The difference in the prognosis of the lateral lymph node metastasis positive (LLNM +) and lateral lymph node metastasis negative (LLNM-) groups was assessed.ResultsThere were 31 patients (10.6%) who were diagnosed with a complete response by hematoxylin and eosin (HE) staining. The residual cancer cells showed complete apoptosis in the primary lesion in 28 patients, in the metastatic MLN in only two patients, and in the metastatic LLN in one patient. The LLNM + group had a significantly poorer distant recurrence, recurrence-free survival, and overall survival than the LLNM- group.ConclusionThe majority of the residual cancer tissue in LNs observed by HE staining was found to be non-apoptotic. If LLN metastasis is suspected on pretreatment imaging, performing LLN dissection together with TME should be considered.
登录
查看更多内容
DOI:
10.6004/jnccn.2018.0061
发表时间:
2018-07
期刊:
Journal of the National Comprehensive Cancer Network : JNCCN
影响因子:
--
作者:
Benson AB;Venook AP;Al-Hawary MM;Cederquist L;Chen YJ;Ciombor KK;Cohen S;Cooper HS;Deming D;Engstrom PF;Grem JL;Grothey A;Hochster HS;Hoffe S;Hunt S;Kamel A;Kirilcuk N;Krishnamurthi S;Messersmith WA;Meyerhardt J;Mulcahy MF;Murphy JD;Nurkin S;Saltz L;Sharma S;Shibata D;Skibber JM;Sofocleous CT;Stoffel EM;Stotsky-Himelfarb E;Willett CG;Wuthrick E;Gregory KM;Gurski L;Freedman-Cass DA
通讯作者:
Freedman-Cass DA
影响因子:
3.9
作者:
Kawai, Kazushige;Shiratori, Hiroshi;Ishihara, Soichiro
通讯作者:
Ishihara, Soichiro
影响因子:
3.3
作者:
K. Dirschmid;Alois Lang;G. Mathis;A. Haid;M. Hansen
通讯作者:
M. Hansen
影响因子:
3.9
作者:
Nagawa, H;Muto, T;Sawada, T
通讯作者:
Sawada, T
影响因子:
3
作者:
HOJO, K;KOYAMA, Y;MORIYA, Y
通讯作者:
MORIYA, Y